AMERICAN ONCOLOGY NETWORK IN (AONC) Fundamental Analysis & Valuation

NASDAQ:AONC • US0287191029

Current stock price

2.14 USD
+0.44 (+25.88%)
At close:
1.75 USD
-0.39 (-18.22%)
After Hours:

This AONC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AONC Profitability Analysis

1.1 Basic Checks

  • AONC had negative earnings in the past year.
  • In the past year AONC had a positive cash flow from operations.
AONC Yearly Net Income VS EBIT VS OCF VS FCFAONC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 10M -10M 20M -20M -30M

1.2 Ratios

  • AONC's Return On Assets of -4.43% is in line compared to the rest of the industry. AONC outperforms 43.48% of its industry peers.
Industry RankSector Rank
ROA -4.43%
ROE N/A
ROIC N/A
ROA(3y)2.93%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AONC Yearly ROA, ROE, ROICAONC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5

1.3 Margins

  • Looking at the Gross Margin, with a value of 8.08%, AONC is doing worse than 79.13% of the companies in the same industry.
  • AONC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AONC Yearly Profit, Operating, Gross MarginsAONC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 2 4 6

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. AONC Health Analysis

2.1 Basic Checks

  • AONC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AONC has less shares outstanding than it did 1 year ago.
  • The debt/assets ratio for AONC is higher compared to a year ago.
AONC Yearly Shares OutstandingAONC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M
AONC Yearly Total Debt VS Total AssetsAONC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

  • AONC has an Altman-Z score of 1.88. This is not the best score and indicates that AONC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • AONC has a Altman-Z score (1.88) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of AONC is 7.44, which is on the high side as it means it would take AONC, 7.44 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of AONC (7.44) is better than 70.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.44
Altman-Z 1.88
ROIC/WACCN/A
WACC9.52%
AONC Yearly LT Debt VS Equity VS FCFAONC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.39 indicates that AONC should not have too much problems paying its short term obligations.
  • AONC has a Current ratio of 1.39. This is comparable to the rest of the industry: AONC outperforms 51.30% of its industry peers.
  • AONC has a Quick Ratio of 1.20. This is a normal value and indicates that AONC is financially healthy and should not expect problems in meeting its short term obligations.
  • AONC has a Quick ratio (1.20) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.2
AONC Yearly Current Assets VS Current LiabilitesAONC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. AONC Growth Analysis

3.1 Past

  • AONC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1431.78%.
EPS 1Y (TTM)-1431.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5307.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AONC Yearly Revenue VS EstimatesAONC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 200M 400M 600M 800M 1B

More info and screens

Find the best growth stocksShow best growing peers

2

4. AONC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AONC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AONC Price Earnings VS Forward Price EarningsAONC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • AONC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AONC is cheaper than 95.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.78
EV/EBITDA N/A
AONC Per share dataAONC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AONC Dividend Analysis

5.1 Amount

  • No dividends for AONC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

AONC Fundamentals: All Metrics, Ratios and Statistics

AMERICAN ONCOLOGY NETWORK IN

NASDAQ:AONC (6/7/2024, 8:07:59 PM)

After market: 1.75 -0.39 (-18.22%)

2.14

+0.44 (+25.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.07%
Inst Owner Change0%
Ins Owners24.9%
Ins Owner Change0%
Market Cap78.69M
Revenue(TTM)1.02B
Net Income(TTM)-18.68M
AnalystsN/A
Price TargetN/A
Short Float %0.11%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF 6.78
P/OCF 2.81
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.4
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.32
FCFY14.75%
OCF(TTM)0.76
OCFY35.61%
SpS27.87
BVpS-2.79
TBVpS-2.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.43%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.08%
FCFM 1.13%
ROA(3y)2.93%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.44
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.2
Altman-Z 1.88
F-Score4
WACC9.52%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1431.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5307.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1151.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2622.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6191.09%
OCF growth 3YN/A
OCF growth 5YN/A

AMERICAN ONCOLOGY NETWORK IN / AONC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AMERICAN ONCOLOGY NETWORK IN?

ChartMill assigns a fundamental rating of 1 / 10 to AONC.


What is the valuation status for AONC stock?

ChartMill assigns a valuation rating of 2 / 10 to AMERICAN ONCOLOGY NETWORK IN (AONC). This can be considered as Overvalued.


What is the profitability of AONC stock?

AMERICAN ONCOLOGY NETWORK IN (AONC) has a profitability rating of 1 / 10.


How financially healthy is AMERICAN ONCOLOGY NETWORK IN?

The financial health rating of AMERICAN ONCOLOGY NETWORK IN (AONC) is 3 / 10.